| Name: | Efavirenz Related Compound A |
| Catalogue No. | VL1680004 |
| CAS No. | 209414-27-7 |
| Molecular Formula | C13H11ClF3NO |
| Molecular Weight | 289.68 |
| Status | In-stock |
| IUPAC Name | (S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol |
| Synonyms | Efavirenz IP Impurity E / Efavirenz Amino Alcohol |
| Description | Efavirenz Related Compound A or Efavirenz IP Impurity E /Efavirenz Amino Alcohol (CAS No.209414-27-7) or (S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that shows inhibitory action against HIV-1. It is a benzoxazinone and orally active compound. |
| References | "Adkins, Julie C., and Stuart Noble. “Efavirenz.” Drugs, vol. 56, no. 6, 1998, pp. 1055–64, https://doi.org/10.2165/00003495-199856060-00014. Kenedi, Christopher A., and Harold W. Goforth. “A Systematic Review of the Psychiatric Side-Effects of Efavirenz.” AIDS and Behavior, vol. 15, no. 8, Apr. 2011, pp. 1803–18, https://doi.org/10.1007/s10461-011-9939-5. " |
